Prime Islami Life Insurance Limited announcements
319 Dhaka Stock Exchange announcements for Prime Islami Life Insurance Limited (PRIMELIFE) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2024 (23).
- Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended December 31, 2023 to the respective shareholders.
- (Q3 Un-audited): As per life revenue account of the company for July to September, 2024, excess of total expenses includ
(Q3 Un-audited): As per life revenue account of the company for July to September, 2024, excess of total expenses including claims over total income (deficit) was BDT 68.95 million as against excess of total income over total expenses including claims (surplus) of BDT 13.19 million in the corresponding previous period of 2023. Whereas as per life revenue account of the company for January to September, 2024, excess of total expenses including claims over total income (cont.)
- Q3 Financials
(Continuation news of PRIMELIFE): (deficit) was BDT 777.29 million as against excess of total expenses including claims over total income (deficit) of BDT 794.09 million in the corresponding previous period of 2023. Accordingly, Balance of Life Insurance Fund was BDT 6,796.21 million as on September 30, 2024 as against BDT 6,919.24 million as on September 30, 2023 resulting a net decrease of BDT 123.03 million. (end)
The first part of this announcement is missing from the archive. - Valuation Report as at December 31, 2021
The company has informed that the Board of Directors has approved the valuation report as at December 31, 2021 as follows: Net Liability: BDT 14,847,472,970.00, Surplus/Deficit: BDT (-) 6,769,948,990.00 and Balance of Life Insurance Fund: BDT 8,077,523,980.00.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 16, 2024 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended September 30, 2024.
- Resumption after Record date
Trading of the shares of the company will resume on 14.10.2024.
- Suspension for record date
Trading of the shares of the company will remain suspended on record date i.e., 09.10.2024.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 07.10.2024 to 08.10.2024 and trading of the shares of the company will remain suspended on record date i.e., 09.10.2024.
- The company has requested the shareholders to update their Bank Accounts, Address, Mobile number, 12 digits e-TIN number
The company has requested the shareholders to update their Bank Accounts, Address, Mobile number, 12 digits e-TIN number through their respective DP. The Record Date is 09.10.2024. Merchant Banks and Brokerage Houses are also requested to provide a statement with details (Shareholders\' name, BO ID number, 12 digits e-TIN Number, Number of shares held, Gross dividend receivable, applicable tax rate) of their margin loan holders who hold shares of the Company (cont.)
- Update of Information
(Continuation news of PRIMELIFE): on the record date along with the name and mobile number of the contact person within October 20, 2024 and soft data to e-mail [email protected]. (end)
The first part of this announcement is missing from the archive. - Qualified Opinion and Emphasis of Matter
The auditor of the company has given the "Qualified Opinion and Emphasis of Matter" paragraph in the Auditor's Report of the company for the year ended December 31, 2023. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2024/September/PRIMELIFE_2023.pdf
- (Q1 Un-audited): As per consolidated life revenue account of the company for January to March, 2024, excess of total exp
(Q1 Un-audited): As per consolidated life revenue account of the company for January to March, 2024, excess of total expenses including claims over total income (deficit) was BDT 746.92 million as against excess of total expenses including claims over total income (deficit) of BDT 751.18 million in the corresponding previous period of 2023. (cont.)
- (Q2 Un-audited): As per consolidated life revenue account of the company for April to June, 2024, excess of total income
(Q2 Un-audited): As per consolidated life revenue account of the company for April to June, 2024, excess of total income over total expenses including claims (surplus) was BDT 38.58 million as against excess of total expenses including claims over total income (deficit) of BDT 56.10 million in the corresponding previous period of 2023. Whereas as per consolidated life revenue account of the company for January to June, 2024, excess of total expenses including claims over total income (deficit) (cont.)
- Dividend Declaration
The Board of Directors has recommended 1% Cash Dividend for the year ended December 31, 2023. Date of AGM: 06.11.2024, Time: 12:00 PM, Venue: 112, Kazi Nazrul Islam Avenue, Bangla Motor, Dhaka through using Hybrid System. Record Date: 09.10.2024.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (29.08.2024) following its corporate declaration.
- Q1 Financials
(Continuation news of PRIMELIFE): Accordingly, Balance of Life Insurance Fund as on March 31, 2024 was BDT 6,826.58 million as against BDT 6,962.15 million as on March 31, 2023 resulting a net decrease of BDT 135.57 million. (end)
The first part of this announcement is missing from the archive. - Q2 Financials
(Continuation news of PRIMELIFE): was BDT 708.34 million as against excess of total expenses including claims over total income (deficit) of BDT 807.29 million in the corresponding previous period of 2023. Accordingly, Balance of Life Insurance Fund was BDT 6,865.15 million as on June 30, 2024 as against BDT 6,906.04 million as on June 30, 2023 resulting a net decrease of BDT 40.89 million. (end)
The first part of this announcement is missing from the archive. - Reschedule of Board Meeting under LR 19(1)
The Company has further informed that, the Board meeting under LR 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on August 28, 2024 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2023.
- Reschedule of Board Meeting under LR 16(1)
The Company has further informed that the meeting of the Board of Directors of the Company as per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on August 28, 2024 at 03:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended March 31, 2024 and Second Quarter (Q2) period ended June 30, 2024.
- Postponement of Board Meeting schedule under LR 19(1)
The Company has further informed that due to unavoidable circumstances, the meeting scheduled to be held on August 08, 2024 at 02:30 PM as per LR 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, to consider, among others, audited financial statements of the Company for the year ended December 31, 2023, has been postponed. New date and time of the meeting will be notified later.
- Postponement of Board Meeting schedule under LR 16(1)
The Company has further informed that due to unavoidable circumstances, the meeting scheduled to be held on August 08, 2024 at 02:30 PM as per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended March 31, 2024 and Second Quarter (Q2) period ended June 30, 2024, has been postponed. New date and time of the meeting will be notified later.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on August 08, 2024 at 02:30 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2023.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on August 08, 2024 at 02:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended March 31, 2024 and Second Quarter (Q2) period ended June 30, 2024.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.